Future of ChatGPT in Pharmacovigilance Hanyin WangYanyi Jenny DingYuan Luo Editorial 12 June 2023 Pages: 711 - 713
Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review Anne-Sophie GarnierGuillaume DrablierJean-François Augusto Review Article 13 June 2023 Pages: 715 - 724
Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review Sharon E. DavisLuke ZabotkaJoshua C. Smith Scoping Review 20 June 2023 Pages: 725 - 742
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data Fahed Al-AzzawiIsraa MahmoudMaurizio Sessa Original Research Article Open access 10 June 2023 Pages: 743 - 751
Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012–2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate Patrick E. BeelerThomas StammschulteHolger Dressel Original Research Article Open access 19 June 2023 Pages: 753 - 763
Provision and Characterization of a Corpus for Pharmaceutical, Biomedical Named Entity Recognition for Pharmacovigilance: Evaluation of Language Registers and Training Data Sufficiency Jürgen DietrichPhilipp Kazzer Original Research Article Open access 20 June 2023 Pages: 765 - 779
Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques Siun KimTaegwan KangHoward Lee Original Research Article Open access 17 June 2023 Pages: 781 - 795
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance Faaizah ArshadMartijn J. SchuemieMarc A. Suchard Original Research Article Open access 16 June 2023 Pages: 797 - 807
Comment on “Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” Jürgen O. Kirchner Letter to the Editor 27 May 2023 Pages: 809 - 811
Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” Corinne WillameDaniel WeibelMiriam C. J. M. Sturkenboom Letter to the Editor 27 May 2023 Pages: 813 - 815
Correction to: Comment on: “Should Antidepressants be Avoided in Pregnancy?” Alain BraillonSusan BewleyFlorian Naudet Correction 16 May 2023 Pages: 817 - 817